New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Jemal, 2007, Cancer statistics, 2007, CA Cancer J Clin, 57, 43, 10.3322/canjclin.57.1.43 Ferlay, 2007, Estimates of the cancer incidence and mortality in Europe in 2006, Ann Oncol, 18, 581, 10.1093/annonc/mdl498 Berrino, 2007, Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study, Lancet Oncol, 8, 773, 10.1016/S1470-2045(07)70245-0 Key, 2007, Cancer of the pancreas Conlon, 1996, Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors, Ann Surg, 223, 273, 10.1097/00000658-199603000-00007 Sohn, 2000, Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators, J Gastrointest Surg, 4, 567, 10.1016/S1091-255X(00)80105-5 Furukawa, 1996, Clinicopathologic features of small pancreatic adenocarcinoma. A collective study, Cancer, 78, 986, 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A Shimizu, 2005, Small carcinoma of the pancreas is curable: new computed tomography finding, pathological study and postoperative results from a single institute, J Gastroenterol Hepatol, 20, 1591, 10.1111/j.1440-1746.2005.03895.x Ishikawa, 1999, Minute carcinoma of the pancreas measuring 1 cm or less in diameter—collective review of Japanese case reports, Hepatogastroenterology, 46, 8 Tsuchiya, 1986, Collective review of small carcinomas of the pancreas, Ann Surg, 203, 77, 10.1097/00000658-198601000-00013 Hruban, 2000, Progression model for pancreatic cancer, Clin Cancer Res, 6, 2969 Brat, 1998, Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas, Am J Surg Pathol, 22, 163, 10.1097/00000478-199802000-00003 Gangi, 2004, Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis, Am J Roentgenol, 182, 897, 10.2214/ajr.182.4.1820897 Pelaez-Luna, 2007, Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis, Am J Gastroenterol, 102, 2157, 10.1111/j.1572-0241.2007.01480.x Chari, 2007, Detecting pancreatic cancer early: problems and prospects, Semin Oncol, 34, 284, 10.1053/j.seminoncol.2007.05.005 Canto, 2004, Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach, Clin Gastroenterol Hepatol, 2, 606, 10.1016/S1542-3565(04)00244-7 Brentnall, 1999, Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer, Ann Intern Med, 131, 247, 10.7326/0003-4819-131-4-199908170-00003 Goggins, 2000, Can we screen high-risk individuals to detect early pancreatic carcinoma?, J Surg Oncol, 74, 243, 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C Everhart, 1995, Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis, JAMA, 273, 1605, 10.1001/jama.1995.03520440059037 Huxley, 2005, Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies, Br J Cancer, 92, 2076, 10.1038/sj.bjc.6602619 Noy, 1994, Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy, J Clin Endocrinol Metab, 79, 1223 Permert, 1993, Pancreatic cancer is associated with impaired glucose metabolism, Eur J Surg, 159, 101 Cersosimo, 1991, Insulin secretion and action in patients with pancreatic cancer, Cancer, 67, 486, 10.1002/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1 2007, Diagnosis and classification of diabetes mellitus, Diabetes Care, 30, S42, 10.2337/dc07-S042 Pannala, 2008, Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus, Gastroenterology, 134, 981, 10.1053/j.gastro.2008.01.039 Chari, 2001, Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer, Gastroenterology, 121, 640, 10.1053/gast.2001.27210 Gullo, 1994, Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group, N Engl J Med, 331, 81, 10.1056/NEJM199407143310203 Chari, 2008, Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer, Gastroenterology, 134, 95, 10.1053/j.gastro.2007.10.040 Permert, 1993, Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer, Br J Surg, 80, 1047, 10.1002/bjs.1800800841 Fogar, 1994, Diabetes mellitus in pancreatic cancer follow-up, Anticancer Res, 14, 2827 Basso, 2004, Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes, Gut, 53, 1159, 10.1136/gut.2003.024471 Valerio, 1999, Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved, Biochem Biophys Res Commun, 257, 622, 10.1006/bbrc.1999.0521 Wang, 1997, Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines, Int J Pancreatol, 21, 157, 10.1007/BF02822387 Wang, 1998, In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets, J Surg Res, 79, 13, 10.1006/jsre.1998.5393 Basso, 1995, The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice, Anticancer Res, 15, 2585 Chari, 2005, Probability of pancreatic cancer following diabetes: a population-based study, Gastroenterology, 129, 504, 10.1016/j.gastro.2005.05.007 Green, 1958, Diabetes mellitus in association with primary carcinoma of the pancreas, Diabetes, 7, 308, 10.2337/diab.7.4.308 Tsuchiya, 1986, Collective review of small carcinomas of the pancreas, Ann Surg, 203, 77, 10.1097/00000658-198601000-00013 2008, Standards of medical care in diabetes—2008, Diabetes Care, 31, S12, 10.2337/dc08-S012 Yusoff, 2004, A prospective, quantitative assessment of the effect of ethanol and other variables on the endosonographic appearance of the pancreas, Clin Gastroenterol Hepatol, 2, 405, 10.1016/S1542-3565(04)00126-0 Ogawa, 2002, A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus, Cancer, 94, 2344, 10.1002/cncr.10493 Damiano, 2004, Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?, Diabetes Metab, 30, 203, 10.1016/S1262-3636(07)70111-8 Reeves, 2007, Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study, BMJ, 335, 1134, 10.1136/bmj.39367.495995.AE Permert, 1997, Islet hormone secretion in pancreatic cancer patients with diabetes, Pancreas, 15, 60, 10.1097/00006676-199707000-00009 Permert, 1994, Islet amyloid polypeptide in patients with pancreatic cancer and diabetes, N Engl J Med, 330, 313, 10.1056/NEJM199402033300503 Basso, 2006, Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?, Clin Chim Acta, 372, 120, 10.1016/j.cca.2006.03.027 Pfeffer, 2004, Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma, Pancreas, 29, 284, 10.1097/00006676-200411000-00007 Vella, 2004, The gastrointestinal tract and glucose tolerance, Curr Opin Clin Nutr Metab Care, 7, 479, 10.1097/01.mco.0000134375.01310.97 Dinneen, 1992, Carbohydrate metabolism in non-insulin-dependent diabetes mellitus, N Engl J Med, 327, 707, 10.1056/NEJM199209033271007 Nakamura, 1996, Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis, Int J Pancreatol, 20, 169, 10.1007/BF02803765 Bank, 1975, Clinical and hormonal aspects of pancreatic diabetes, Am J Gastroenterol, 64, 13 Isaksson, 2003, Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients, Pancreas, 26, 173, 10.1097/00006676-200303000-00014 Liu, 2000, The intracellular mechanism of insulin resistance in pancreatic cancer patients, J Clin Endocrinol Metab, 85, 1232 Basso, 2002, Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide, Pancreas, 24, 8, 10.1097/00006676-200201000-00002 Ahren, 1993, Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster, Res Exp Med, 193, 21, 10.1007/BF02576207 Katsumichi, 2007, Diabetes mellitus in pancreatic cancer: is it a causal relationship?, Am J Surg, 194, S71, 10.1016/j.amjsurg.2007.05.024 Permert, 1993, Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?, Am J Surg, 165, 61, 10.1016/S0002-9610(05)80405-2 Schwarts, 1978, A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma, Am J Dig Dis, 23, 1107, 10.1007/BF01072886 Fox, 1985, Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation, Diabet Med, 2, 113, 10.1111/j.1464-5491.1985.tb00612.x Basso, 1994, Beta-cell function in pancreatic adenocarcinoma, Pancreas, 9, 332, 10.1097/00006676-199405000-00008 Chari, 2005, Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance, Pancreatology, 5, 229, 10.1159/000085276